Tarec K. Elajami

938 total citations
32 papers, 703 citations indexed

About

Tarec K. Elajami is a scholar working on Cardiology and Cardiovascular Medicine, Nutrition and Dietetics and Surgery. According to data from OpenAlex, Tarec K. Elajami has authored 32 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 9 papers in Nutrition and Dietetics and 7 papers in Surgery. Recurrent topics in Tarec K. Elajami's work include Fatty Acid Research and Health (9 papers), Cardiovascular Disease and Adiposity (7 papers) and Cardiac Imaging and Diagnostics (6 papers). Tarec K. Elajami is often cited by papers focused on Fatty Acid Research and Health (9 papers), Cardiovascular Disease and Adiposity (7 papers) and Cardiac Imaging and Diagnostics (6 papers). Tarec K. Elajami collaborates with scholars based in United States, Lebanon and France. Tarec K. Elajami's co-authors include Francine K. Welty, Abdulhamied Alfaddagh, Bruce R. Bistrian, Nan Chiang, Charles N. Serhan, Jesmond Dalli, Romain A. Colas, Jin‐Rong Zhou, Saberio Lo Presti and Markus Hardt and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The FASEB Journal.

In The Last Decade

Tarec K. Elajami

26 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarec K. Elajami United States 11 268 164 151 145 137 32 703
Robert G. Metcalf Australia 16 483 1.8× 114 0.7× 172 1.1× 96 0.7× 192 1.4× 27 876
Chuchun L. Chang United States 14 187 0.7× 126 0.8× 87 0.6× 80 0.6× 87 0.6× 25 502
Katsuhiko Sumiyoshi Japan 16 116 0.4× 139 0.8× 118 0.8× 116 0.8× 53 0.4× 23 617
Bianca Itariu Austria 15 279 1.0× 209 1.3× 220 1.5× 304 2.1× 123 0.9× 30 1.1k
Katsuya Yamazaki Japan 18 162 0.6× 197 1.2× 162 1.1× 276 1.9× 82 0.6× 49 1.2k
Olfa Helal France 13 168 0.6× 189 1.2× 268 1.8× 110 0.8× 48 0.4× 17 876
C. Thevenon France 13 262 1.0× 152 0.9× 126 0.8× 50 0.3× 66 0.5× 17 634
Pablo Stiefel Spain 18 156 0.6× 177 1.1× 178 1.2× 98 0.7× 29 0.2× 60 927
Asuka Hino Japan 9 96 0.4× 71 0.4× 139 0.9× 142 1.0× 30 0.2× 14 694
Urszula Raźny Poland 14 129 0.5× 73 0.4× 44 0.3× 122 0.8× 68 0.5× 36 656

Countries citing papers authored by Tarec K. Elajami

Since Specialization
Citations

This map shows the geographic impact of Tarec K. Elajami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarec K. Elajami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarec K. Elajami more than expected).

Fields of papers citing papers by Tarec K. Elajami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarec K. Elajami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarec K. Elajami. The network helps show where Tarec K. Elajami may publish in the future.

Co-authorship network of co-authors of Tarec K. Elajami

This figure shows the co-authorship network connecting the top 25 collaborators of Tarec K. Elajami. A scholar is included among the top collaborators of Tarec K. Elajami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarec K. Elajami. Tarec K. Elajami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baral, Nischit, Elena Deych, Tarec K. Elajami, et al.. (2025). Trend of cardiovascular mortality among metastatic renal cell cancer patients in the US from 2005 to 2020. Cancer Epidemiology. 95. 102758–102758.
2.
Elajami, Tarec K., et al.. (2025). CARDIAC TOLL OF PERFORMANCE ENHANCEMENT: A RARE CASE OF CARDARINE-INDUCED DILATED CARDIOMYOPATHY. Journal of the American College of Cardiology. 85(12). 3054–3054.
3.
Baral, Nischit, et al.. (2025). Trends of all-cause, melanoma-specific, and cardiovascular mortality in melanoma patients from 2005 to 2020. Cancer Epidemiology. 97. 102848–102848.
4.
Golamari, Reshma, et al.. (2025). Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression. Journal of Thoracic Disease. 17(7). 5108–5121. 1 indexed citations
5.
Prokop, Larry, et al.. (2025). Prognostic value of baseline RV dysfunction using TAPSE and TAPSE to PASP ratio in patients undergoing mitra-clip: a systematic review and meta-analysis. The International Journal of Cardiovascular Imaging. 41(5). 827–846.
6.
Klein, Benjamin, Nicole Fernandez, Miguel Urina‐Triana, et al.. (2025). Efficacy of GLP ‐1 receptor agonists in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled trials. Diabetes Obesity and Metabolism. 27(12). 7030–7039. 1 indexed citations
7.
Golamari, Reshma, Francisco Ujueta, Christos G. Mihos, et al.. (2024). Left bundle branch area pacing in heart failure: A systematic review and meta‐analysis with meta‐regression. Journal of Cardiovascular Electrophysiology. 35(8). 1536–1547. 4 indexed citations
8.
Mihos, Christos G., et al.. (2024). Interventricular Septal Involvement Is Associated with More Impaired Ventricular Function and Mechanics in Apical Hypertrophic Cardiomyopathy. Journal of Cardiovascular Development and Disease. 11(3). 74–74.
11.
Presti, Saberio Lo, et al.. (2021). Multimodality imaging in the diagnosis and management of prosthetic valve endocarditis: A contemporary narrative review. World Journal of Cardiology. 13(8). 254–270. 19 indexed citations
12.
Welty, Francine K., Fabian Schulte, Abdulhamied Alfaddagh, et al.. (2021). Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid + resolvin E1) to leukotriene B 4. The FASEB Journal. 35(4). e21448–e21448. 46 indexed citations
13.
Presti, Saberio Lo, Tarec K. Elajami, Ivan A. Arenas, et al.. (2020). Transthoracic versus intra-operative transesophageal echocardiography in right heart assessment. Journal of Thoracic Disease. 12(5). 2955–2962. 2 indexed citations
15.
Alfaddagh, Abdulhamied, et al.. (2017). Abstract 17391: Omega-3 Fatty Acid Index ≥ 4% Prevents Progression of Coronary Artery Plaque in Non-Diabetic Subjects on Statin Therapy. Circulation. 1 indexed citations
16.
17.
Elajami, Tarec K., Abdulhamied Alfaddagh, & Francine K. Welty. (2016). Abstract 16353: Triglyceride Reduction With Omega-3 Fatty Acids is Associated With Regression of Coronary Plaque Volume in Subjects With Coronary Artery Disease on Maximal Statin Therapy. Circulation. 134. 1 indexed citations
18.
Alfaddagh, Abdulhamied, Tarec K. Elajami, & Francine K. Welty. (2016). Abstract 16294: Omega-3 Fatty Acid Added to Statin Prevents Progression of Fibrous Coronary Artery Plaque Compared to Statin Alone in Patients With Coronary Artery Disease. Circulation. 1 indexed citations
19.
Elajami, Tarec K., et al.. (2016). Ischemic stroke in a young adult with extremely elevated lipoprotein(a): A case report and review of literature. Journal of clinical lipidology. 10(5). 1266–1271. 4 indexed citations
20.
Elajami, Tarec K., et al.. (2016). Parity, coronary heart disease and mortality in the old order Amish. Atherosclerosis. 254. 14–19. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026